Preliminary clinical assessment and non- toxicity evaluation of an ayurvedic formulation BGR-34 in NIDDM

B.P. Gupta ； I. Sharma ； N. Kohli ； S. Sharma ； A. Rathi ； A.K. Sharma

《Journal of Traditional and Complementary Medicine》 8卷4期 (2018/10) Pp. 506-514

https://doi.org/10.1016/j.jtcme.2017.11.004

摘要

In view of the overall health impact of NIDDM, inventers understand the necessity of improving glycemic control in adults with type 2 diabetes. BGR-34 provides an effective treatment option for adults with type 2 diabetes who have been inadequately controlled on lifestyle with or without other oral hypoglycemic agents (OHGAs) such as metformin, sulfonylurea, or a glitazones. BGR-34 is an appropriate option to consider for addition to a managed care drug formulary. Treatment with BGR-34 produced clinically relevant and statistically significant reductions in all three key measures of glucose control studied -FPG, PPBG and HbA1c- when compared with placebo. BGR-34, showed the promising result with respect to glycemic parameters in NIDDM patient with a significant reduction in fasting blood sugar by 34.3%, postprandial blood sugar 35.5% & glycosylated haemoglobin by 20.31% as compared to placebo group showing a reduction by 13.2%, 10.9% & 10.87% respectively. The trial has also been registered to CTRI, India. This study has been registered in the clinical trial registry-India.

關鍵字

BGR-34 ； Berberis aristata ； NIDDM ； Indian system medicine ； Type 2 diabetes

參考文獻

World health organization. Global Report on Diabetes. 2016. 2. International Diabetes Federation. 2015.

Michael B, Christian M, Stephan K, Susan S, Jick C, Meier R. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia a nested case-control analysis. Diabetes Care. 2008;31(11): 2086-2091.

UK prospective diabetes study (UKPDS) group effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.

Rituparna C, Bhavtaran S, Narendra P, et al. Dipeptidyl peptidase- IV inhibitory activity of Berberis aristata. J Nat Prod. 2011;4:158-163.

Marimuthu K, Sangeetha HR, Balaji RV, Gayathri HR, Vasanthi. Tinospora cordifolia attenuates oxidative stress and distorted carbohydrate metabolism in experimentally induced type 2 diabetes in rats. J Nat Med. 2011;65:544.